Catherine Guezennec

ORCID: 0000-0003-4871-6086
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging Techniques and Applications
  • Head and Neck Cancer Studies
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Treatment and Research
  • Medical Imaging and Pathology Studies
  • Lymphoma Diagnosis and Treatment
  • Colorectal and Anal Carcinomas
  • Adrenal and Paraganglionic Tumors
  • Radiation Dose and Imaging
  • Appendicitis Diagnosis and Management
  • Gastric Cancer Management and Outcomes
  • Cancer Diagnosis and Treatment
  • Diverticular Disease and Complications
  • Advanced X-ray and CT Imaging
  • Esophageal Cancer Research and Treatment
  • Anorectal Disease Treatments and Outcomes
  • Lung Cancer Treatments and Mutations

Hôpital Antoine-Béclère
2024

Assistance Publique – Hôpitaux de Paris
2024

Centre Hospitalier Régional Universitaire de Brest
2016-2021

King's College London
2021

Abstract Background This study aimed at assessing the prognostic value of textural indices extracted from 18F‐fluorodeoxyglucose positron‐emission tomography (FDG‐PET)/CT in a large cohort patients with head and neck squamous cell carcinomas (HNSCC) any anatomic subsite staging. Methods Consecutive HNSCC referred for pretreatment FDG‐PET/CT were retrospectively included followed up minimum 2 years. Standardized uptake value, metabolic tumor volume (MTV), calculated using LIFEx software....

10.1002/hed.25433 article EN Head & Neck 2018-12-14

Aim Characterizing tumor heterogeneity with textural indices extracted from 18F-fluorodeoxyglucose positron emission tomography (FDG PET/CT) is of growing interest in oncology. Several series showed promising results to predict survival patients head and neck squamous cell carcinoma (HNSCC), analyzing various segmentation methods indices. This preliminary study aimed at assessing the inter-observer inter-segmentation method variability HNSCC pre-therapeutic FDG PET/CT. Materials Consecutive...

10.1371/journal.pone.0214299 article EN cc-by PLoS ONE 2019-03-28

SPECT/CT has been shown to increase the diagnostic performance of bone scintigraphy for staging malignancies. A systematic double-bed trunk may allow further improvement. However, this would be balanced by higher dosimetry and longer acquisition time. The objective was assess incremental utility a in initial cancer patients, especially compared with usual approach consisting whole body planar scan (WBS) plus one single-bed targeted SPECT/CT. One hundred two consecutive patients referred...

10.1186/s40644-017-0118-4 article EN cc-by Cancer Imaging 2017-06-07
Charles Sabbagh Laura Beyer‐Berjot Mehdi Ouaïssi Philippe Zerbib Valérie Bridoux and 95 more Gilles Manceau Mehdi Karoui Yves Panís Étienne Buscail Aurélien Venara Iman Khaoudy Martin Gaillard Pablo Ortega‐Deballon Manon Viennet Alexandre Thobie Benjamin Menahem Clarisse Eveno C. Bonnel Jean‐Yves Mabrut Bogdan Badic C. Godet Yassine Eid Émilie Duchalais Zaher Lakkis Eddy Cotte A. Laforest Véronique Defourneaux Léon Maggiorri Lionel Rebibo Niki Christou Andrew H. Talal Diane Mège C. Bonnamy Adeline Germain F. Mauvais C. Trésallet Ahmed Osman Jean‐Marc Regimbeau Jean Roudié Alexis Laurent Bertrand Trilling Martin Bertrand Damien Massalou B. Romain Hadrien Tranchart Urs Giger Olivier Dejardin Alexandra Pellegrin Arnaud Alvès D. Jeanne Jean-Luc Gillet A. Hamy Amine Lahmidi Mylene Sebbagh Antoine Bres Nicolas Girard A. Desjouis Najib Ainseba Julien Epailly Fabienne Huysman Maud Dezeustre Alexandre Doussot Célia Turco Diane Bourrhis C. Godet Maurizio Finocchi Y. Marion G. Lebreton François Bénard Emmanuelle Pineau Véronique Bouvier Olivier Dejardin Manon Viennet Nathan Moreno-Lopez Patrick Rat Bassem Makar Paola Fara Madia Pompilio Hugo Hertault Catherine Guezennec Harumi Saida Adrian Brînză L. Plard Antoine Ailhaud L Gutiérrez Vincent Venchiarutti Jean‐Luc Faucheron B Morin Bertrand Pech de la clause Églantine Voitellier G. Gagnat Barbara Noiret Caroline Laroye Guillaume Piessen Katia Lécolle J Robert Nzamushelepanmabla Pierre Engel Muriel Mathonnet C. Rodriguez

10.1007/s10151-023-02906-y article EN Techniques in Coloproctology 2024-02-19

Background: The objective of this study was to assess the therapeutic and prognostic impact integrating18F-fluorodeoxyglucose (18-FDG) positron emission tomography (PET)/computed (CT) into work-up (WU) at initial staging patients with head neck squamous cell carcinoma (HNSCC). Method: 477 consecutive (414M/63F, mean age 62.3 ± 9.7 years) newly diagnosed HNSCC who underwent pre-treatment 18-FDG PET/CT were retrospectively included. stage (sPET) compared conventional (sCWU). A group cancer...

10.3389/fmed.2020.00273 article EN cc-by Frontiers in Medicine 2020-06-26

PET Textural indices could have an add-on diagnostic value for diagnosis of malignancy in patients with FDG-avid adrenal lesions.Consecutive referred a FDG-PET/CT to our nuclear medicine department from June 2012 2017 were retrospectively screened. Inclusion criteria were: lesion (uptake≥liver background); malignant/benign confirmed histologically or follow-up imaging examination. Pheochromocytomas not included the analysis. For each lesion, 5 quantitative parameters (SUV<inf>max</inf>, MTV,...

10.23736/s1824-4785.19.03138-8 article EN The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021-03-01

Background: The risk of treatment failure in Hodgkin lymphoma (HL) might be assessed more accurately by incorporating presentation features such as disease severity using FDG-PET characteristics to guide the intensity initial therapy. Methods: Twenty-four baseline clinical and PET factors were evaluated UK RATHL1 population including metabolic tumour volume (MTV), tumor lesion glycolysis SUV metrics. association with a HL event, defined positive interim scan at cycle 2 ABVD, or relapse after...

10.1002/hon.73_2879 article EN Hematological Oncology 2021-06-01
Coming Soon ...